The Veteran's claim for increased ratings for service-connected adenocarcinoma of the prostate, status post radiation therapy was denied. The rating prior to February 12, 2013 was found not to meet criteria for a higher than 10 percent rating due to voiding dysfunction or urinary tract infection symptoms. For the period as of February 12, 2013, the Veteran's condition did not warrant a higher than 20 percent rating based on his reported symptoms and medical evidence.
The deciding factor: The Veteran’s service-connected adenocarcinoma of the prostate manifested with daytime voiding intervals between one to two hours or awakening to void three to four times per night, which did not meet criteria for higher ratings under VA's rating criteria.
- Claimed conditions
- adenocarcinoma of the prostate
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- October 19, 2020
- Citation
- 20067658
Veterans Law Judge
Decisions by this judge: 2,677 · Granted: 26% (granted or partly granted, in the indexed decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 20067658.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's adenocarcinoma of the prostate is rated at 60 percent effective February 5, 2021. An effective date of August 5, 2020 for a 20 percent rating for diabetes mellitus type II has been granted. The Veteran's bilateral hearing loss and verruca vulgaris of the right hand are not rated as compensable.
- Whole decision: Denied
The Veteran's cause of death, cardiorespiratory arrest and adult failure to thrive, is not service-connected as there is no evidence linking these conditions to his military service or exposure to herbicide agents. The Board finds that the medical evidence does not support a finding of service connection.
- Whole decision: Granted
The Veteran's prostate condition was restored to a 60% rating effective December 16, 2025.,An earlier effective date of August 23, 2012, for the grant of TDIU is granted.,SMC at the housebound rate is granted effective September 4, 2025.
- Whole decision: Granted
The Veteran's service-connected disabilities, including prostate cancer and urothelial cell carcinoma of the bladder, tinnitus, and urethritis, have prevented him from securing or following substantially gainful employment. The Board has granted a TDIU based on these conditions.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.